Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells

被引:60
作者
Tenedini, E
Fagioli, ME
Vianelli, N
Tazzari, PL
Ricci, F
Tagliafico, E
Ricci, P
Gugliotta, L
Martinelli, G
Tura, S
Baccarani, M
Ferrari, S
Catani, L
机构
[1] Policlin S Orsola, Ist Ematol & Oncol Med L&A Seragnoli, Serv Med Trasfus, I-40138 Bologna, Italy
[2] Univ Bologna, Ist Ematol & Oncol Med L&A Seragnoli, Bologna, Italy
[3] Univ Modena, Dipartimento Sci Biomed, Sez Chim Biol, I-41100 Modena, Italy
[4] Arcispedale S Maria Nuova, Unita Operat Emato, Reggio Emilia, Italy
关键词
D O I
10.1182/blood-2003-07-2597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene expression profiles of bone marrow (BM) CD34-derived megakaryocytic cells (MKs) were compared in patients with essential thrombocythemia (ET) and healthy subjects using oligonucleotide microarray analysis to identify differentially expressed genes and disease-specific transcripts. We found that proapoptotic genes such as BAX, BNIP3, and BNIP3L were down-regulated in ET MKs together with genes that are components of the mitochondrial permeability transition pore complex, a system with a pivotal role in apoptosis. Conversely, antiapoptotic genes such as IGF1-R and CFLAR were up-regulated in the malignant cells, as was the SDF1 gene, which favors cell survival. On the basis of the array results, we characterized apoptosis of normal and ET MKs by time-course evaluation of annexin-V and sub-G1 peak DNA stainings of immature and mature MKs after culture in serum-free medium tration, and annexin-V-positive MKs only, with decreasing thrombopoietin concentrations. ET MKs were more resistant to apoptosis than their normal counterparts. We conclude that imbalance between proliferation and apoptosis seems to be an important-step in malignant ET megakaryocytopoiesis. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:3126 / 3135
页数:10
相关论文
共 62 条
  • [11] CD9 and megakaryocyte differentiation
    Clay, D
    Rubinstein, E
    Mishal, Z
    Ano, A
    Prenant, M
    Jasmin, C
    Boucheix, C
    Le Bousse-Kerdiles, MC
    [J]. BLOOD, 2001, 97 (07) : 1982 - 1989
  • [12] Cripe LD, 1998, SEMIN HEMATOL, V35, P200
  • [13] HIGH-ACTIVITY SUPPRESSION OF MYELOID PROGENITOR PROLIFERATION BY CHIMERIC MUTANTS OF INTERLEUKIN-8 AND PLATELET FACTOR-4
    DALY, TJ
    LAROSA, GJ
    DOLICH, S
    MAIONE, TE
    COOPER, S
    BROXMEYER, HE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23282 - 23292
  • [14] Platelet formation is the consequence of caspase activation within megakaryocytes
    de Botton, S
    Sabri, S
    Daugas, E
    Zermati, Y
    Guidotti, JE
    Hermine, O
    Kroemer, G
    Vainchenker, W
    Debili, N
    [J]. BLOOD, 2002, 100 (04) : 1310 - 1317
  • [15] DiNoto R, 1997, LEUKEMIA, V11, P1554
  • [16] RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
    Elagib, KE
    Racke, FK
    Mogass, M
    Khetawat, R
    Delehanty, LL
    Goldfarb, AN
    [J]. BLOOD, 2003, 101 (11) : 4333 - 4341
  • [17] Insulin-like growth factors and cancer
    Fürstenberger, G
    Senn, HJ
    [J]. LANCET ONCOLOGY, 2002, 3 (05) : 298 - 302
  • [18] V-JUN COOPERATES WITH V-ERBB TO TRANSFORM THE THROMBOCYTIC MEGAKARYOCYTIC LINEAGE
    GARCIA, M
    SAMARUT, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) : 8837 - 8841
  • [19] Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
    Giraudier, S
    Chagraoui, H
    Komura, E
    Barnache, S
    Blanchet, B
    LeCouedic, JP
    Smith, DF
    Larbret, F
    Taksin, AL
    Moreau-Gachelin, F
    Casadevall, N
    Tulliez, M
    Hulin, A
    Debili, N
    Vainchenker, W
    [J]. BLOOD, 2002, 100 (08) : 2932 - 2940
  • [20] Transcript profiling of human platelets using microaray and serial analysis of gene expression
    Gnatenko, DV
    Dunn, JJ
    McCorkle, SR
    Weissmann, D
    Perrotta, PL
    Bahou, WF
    [J]. BLOOD, 2003, 101 (06) : 2285 - 2293